Staging of intestinal- and diffuse-type gastric cancers with the OLGA and OLGIM staging systems

Alimentary Pharmacology and Therapeutics

Volumn 38, Issue 10, 2013, Pages 1292-1302

  Cho, S J ^a   Choi, I J ^a   Kook, M C ^a   Nam, B H ^a   Kim, C G ^a   Lee, J Y ^a   Ryu, K W ^a   Kim, Y W ^a  

^a National Cancer Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; ARTICLE; CANCER PATIENT; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FAMILY HISTORY; FEMALE; GASTRITIS; HELICOBACTER INFECTION; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LAUREN CLASSIFICATION; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MUCINOUS ADENOCARCINOMA; OPERATIVE LINK GASTRIC INTESTINAL METAPLASIA; OPERATIVE LINK ON GASTRITIS ASSESSMENT; PAPILLARY ADENOCARCINOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SIGNET RING CARCINOMA; SMOKING HABIT; STOMACH CANCER; TUBULAR ADENOCARCINOMA; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; GASTRITIS; HUMANS; INTESTINAL NEOPLASMS; LOGISTIC MODELS; MALE; METAPLASIA; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STOMACH NEOPLASMS;

EID: 84886928477     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12515     Document Type: Article

References (47)

1. Correa P,. Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992; 52: 6735-40.
2. de Vries AC, van Grieken NC, Looman CW, et al,. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology 2008; 134: 945-52.
3. Dixon MF, Genta RM, Yardley JH, Correa P,. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-81.
4. Rugge M, Genta RM,. Staging gastritis: an international proposal. Gastroenterology 2005; 129: 1807-8.
5. Rugge M, Meggio A, Pennelli G, et al,. Gastritis staging in clinical practice: the OLGA staging system. Gut 2007; 56: 631-6.
6. Rugge M, de Boni M, Pennelli G, et al,. Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study. Aliment Pharmacol Ther 2010; 31: 1104-11.
7. Satoh K, Osawa H, Yoshizawa M, et al,. Assessment of atrophic gastritis using the OLGA system. Helicobacter 2008; 13: 225-9.
8. Capelle LG, de Vries AC, Haringsma J, et al,. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc 2010; 71: 1150-8.
9. Rugge M, Fassan M, Pizzi M, et al,. Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment. World J Gastroenterol 2011; 17: 4596-601.
10. Lauren P,. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64: 31-49.
11. Hansson LR, Engstrand L, Nyren O, Lindgren A,. Prevalence of Helicobacter pylori infection in subtypes of gastric cancer. Gastroenterology 1995; 109: 885-8.
12. Ohata H, Kitauchi S, Yoshimura N, et al,. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer 2004; 109: 138-43.
13. Shin A, Kim J, Park S,. Gastric cancer epidemiology in Korea. J Gastric Cancer 2011; 11: 135-40.
14. Lee KS, Oh DK, Han MA, et al,. Gastric cancer screening in Korea: report on the national cancer screening program in 2008. Cancer Res Treat 2011; 43: 83-8.
15. Satoh K, Kimura K, Taniguchi Y, et al,. Biopsy sites suitable for the diagnosis of Helicobacter pylori infection and the assessment of the extent of atrophic gastritis. Am J Gastroenterol 1998; 93: 569-73.
16. Said RM, Cheah PL, Chin SC, Goh KL,. Evaluation of a new biopsy urease test: Pronto Dry, for the diagnosis of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 2004; 16: 195-9.
17. Rugge M, Correa P, Dixon MF, et al,. Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther 2002; 16: 1249-59.
18. Rugge M, Pennelli G, Pilozzi E, et al,. Gastritis: the histology report. Dig Liver Dis 2011; 43 (Suppl. 4): S373-84.
19. Hamilton SR, Aaltonen LA, editors. World Health Organization Classification of Tumours. Pathology and Genetics, Tumours of the Digestive System. Lyon, France: IARC Press, 2000.
20. Hosmer DW, Lemeshow S,. Applied Logistic Regression. 2nd ed. New York: John Wiley & Sons, 2000.
21. Pepe MS,. The Statistical Evaluation of Medical Tests for Classification and Prediction. Oxford, UK: Oxford University Press, 2003.
22. Cho SJ, Choi IJ, Kim CG, et al,. Risk factors associated with gastric cancer in patients with a duodenal ulcer. Helicobacter 2010; 15: 516-23.
23. Abdullah M, Ohtsuka H, Rani AA, Sato T, Syam AF, Fujino MA,. Helicobacter pylori infection and gastropathy: a comparison between Indonesian and Japanese patients. World J Gastroenterol 2009; 15: 4928-31.
24. Naylor GM, Gotoda T, Dixon M, et al,. Why does Japan have a high incidence of gastric cancer? Comparison of gastritis between UK and Japanese patients. Gut 2006; 55: 1545-52.
25. el-Zimaity HM, Graham DY, al-Assi MT, et al,. Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis. Hum Pathol 1996; 27: 35-41.
26. Offerhaus GJ, Price AB, Haot J, et al,. Observer agreement on the grading of gastric atrophy. Histopathology 1999; 34: 320-5.
27. Marcos-Pinto R, Carneiro F, Dinis-Ribeiro M, et al,. First-degree relatives of patients with early-onset gastric carcinoma show even at young ages a high prevalence of advanced OLGA/OLGIM stages and dysplasia. Aliment Pharmacol Ther 2012; 35: 1451-9.
28. Tsai YC, Hsiao WH, Yang HB, et al,. The corpus-predominant gastritis index may serve as an early marker of Helicobacter pylori-infected patients at risk of gastric cancer. Aliment Pharmacol Ther 2013; 37: 969-78.
29. Cheli R, Santi L, Ciancamerla G, Canciani G,. A clinical and statistical follow-up study of atrophic gastritis. Am J Dig Dis 1973; 18: 1061-5.
30. de Vries AC, Meijer GA, Looman CW, et al,. Epidemiological trends of pre-malignant gastric lesions: a long-term nationwide study in the Netherlands. Gut 2007; 56: 1665-70.
31. You WC, Li JY, Blot WJ, et al,. Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer. Int J Cancer 1999; 83: 615-9.
32. Shimoyama T, Fukuda S, Tanaka M, Nakaji S, Munakata A,. Evaluation of the applicability of the gastric carcinoma risk index for intestinal type cancer in Japanese patients infected with Helicobacter pylori. Virchows Arch 2000; 436: 585-7.
33. Dicken BJ, Bigam DL, Cass C, Mackey JR, Joy AA, Hamilton SM,. Gastric adenocarcinoma: review and considerations for future directions. Ann Surg 2005; 241: 27-39.
34. Handa Y, Saitoh T, Kawaguchi M, et al,. Association of Helicobacter pylori and diffuse type gastric cancer. J Gastroenterol 1996; 31 (Suppl. 9): 29-32.
35. Solcia E, Fiocca R, Luinetti O, et al,. Intestinal and diffuse gastric cancers arise in a different background of Helicobacter pylori gastritis through different gene involvement. Am J Surg Pathol 1996; 20 (Suppl. 1): S8-22.
36. Sakitani K, Hirata Y, Watabe H, et al,. Gastric cancer risk according to the distribution of intestinal metaplasia and neutrophil infiltration. J Gastroenterol Hepatol 2011; 26: 1570-5.
37. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001; 49: 347-53.
38. Rugge M, Correa P, Di Mario F, et al,. OLGA staging for gastritis: a tutorial. Dig Liver Dis 2008; 40: 650-8.
39. Rugge M, Fassan M, Pizzi M, et al,. Autoimmune gastritis: histology phenotype and OLGA staging. Aliment Pharmacol Ther 2012; 35: 1460-6.
40. Quach DT, Le HM, Nguyen OT, Nguyen TS, Uemura N,. The severity of endoscopic gastric atrophy could help to predict Operative link on gastritis assessment gastritis stage. J Gastroenterol Hepatol 2011; 26: 281-5.
41. Kim CG, Choi IJ, Lee JY, et al,. Biopsy site for detecting Helicobacter pylori infection in patients with gastric cancer. J Gastroenterol Hepatol 2009; 24: 469-74.
42. Lee JH, Park YS, Choi KS, et al,. Optimal biopsy site for Helicobacter pylori detection during endoscopic mucosectomy in patients with extensive gastric atrophy. Helicobacter 2012; 17: 405-10.
43. Lash JG, Genta RM,. Adherence to the Sydney System guidelines increases the detection of Helicobacter gastritis and intestinal metaplasia in 400 738 sets of gastric biopsies. Aliment Pharmacol Ther 2013; 38: 424-31.
44. Graham DY, Nurgalieva ZZ, El-Zimaity HM, et al,. Noninvasive versus histologic detection of gastric atrophy in a Hispanic population in North America. Clin Gastroenterol Hepatol 2006; 4: 306-14.
45. Eriksson NK, Farkkila MA, Voutilainen ME, Arkkila PE,. The clinical value of taking routine biopsies from the incisura angularis during gastroscopy. Endoscopy 2005; 37: 532-6.
46. Dinis-Ribeiro M, Areia M, de Vries AC, et al,. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 2012; 44: 74-94.
47. Song IC, Lee HJ, Kim HJ, et al,. A multicenter retrospective analysis of the clinical features of pernicious anemia in a korean population. J Korean Med Sci 2013; 28: 200-4.